Back to search

Article

Dose Regimen Optimization of PD-L1 Inhibitor and Nab-paclitaxel in Patients with NSCLC: a Quantitative Systems Pharmacology analysis

2022-12-29

Abstract excerpt

<title>Abstract</title> <p><bold>Introduction:</bold> Combining immune checkpoint inhibitor and chemotherapies provides more benefits than traditional treatment options in patients with NSCLC. However, some patients still have no clinical benefits. Clinical accessible biomarkers are necessary to predict clinical outcomes and optimize dose strategies. The study aimed to investigate accessible biomarkers that can p...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
bf1db5e1-03cc-5c9e-b7a5-b1aa0fda9481
DOI
10.21203/rs.3.rs-2403420/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Dose Regimen Optimization of PD-L1 Inhibitor and Nab-paclitaxel in Patients with NSCLC: a Quantitative Systems Pharmacology analysisDOI 10.21203/rs.3.rs-2403420/v1
Generating immunogenomic data-guided virtual patients using a QSP model to predict response of advanced NSCLC to PD-L1 inhibitionSemantic proximity
Modular mechanistic mathematical models for improved biomarker identification and treatment scheduling in oncologySemantic proximity
Towards a platform quantitative systems pharmacology (QSP) model for preclinical to clinical translation of antibody drug conjugates (ADCs)Semantic proximity
Exploratory Bayesian Synthesis of Targeted Agents Combined With Immune Checkpoint Inhibitors in Advanced Non–Small Cell Lung Cancer: A Network Meta-analysis of Single-Arm StudiesSemantic proximity
Quantitative cancer-immunity cycle modeling for predicting disease progression in advanced metastatic colorectal cancerSemantic proximity
Phase <i>i</i> trials in melanoma: A framework to translate preclinical findings to the clinicSemantic proximity
Informing virtual clinical trials of hepatocellular carcinoma with spatial multi-omics analysis of a human neoadjuvant immunotherapy clinical trialSemantic proximity
Enhancing Predictive Accuracy in Immunotherapy Models through Data Integration and Parameter IdentifiabilitySemantic proximity
Optimized patient-specific immune checkpoint inhibitors therapy for cancer treatment based on tumor immune microenvironment modelingSemantic proximity
Pan-cancer population pharmacokinetics and exposure-safety and -efficacy analyses of atezolizumab in patients with high tumor mutational burden.Semantic proximity
Dynamic optimization of chemo–immunotherapy sequencing reveals phenotype-dependent regimens across tumor immune microenvironmentsSemantic proximity
A Quantitative Systems Pharmacology Model of T Cell Engager Applied to Solid TumorSemantic proximity
Select a neighboring publication to make it the new centre.